IPONOVA — India's IPO Intelligence Platform

Avience Biomedicals Ltd IPO

Upcoming · SME · NSE SME

Last updated:  ·  Compiled by IPONOVA Editorial Desk  ·  How we source data

IPO Details

Price Band₹196.00–₹208.00
Lot Size600 shares
Issue Size₹30 Cr
Open Date18 Jun 26
Close Date22 Jun 26
Listing Date25 Jun 26
ExchangeNSE SME
Subscription-x

About Avience Biomedicals Ltd

Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry.

Frequently Asked Questions

When does the Avience Biomedicals Ltd IPO open and close?
The Avience Biomedicals Ltd IPO opens for subscription on 18 Jun 26. It closes on 22 Jun 26.
What is the price band of Avience Biomedicals Ltd IPO?
The price band of Avience Biomedicals Ltd IPO is ₹196.00 to ₹208.00 per share.
What is the minimum lot size for Avience Biomedicals Ltd IPO?
The minimum lot size for Avience Biomedicals Ltd IPO is 600 shares, requiring a minimum investment of ₹124,800.
When will Avience Biomedicals Ltd list on stock exchanges?
Avience Biomedicals Ltd is expected to list on NSE SME on 25 Jun 26.
How can I check Avience Biomedicals Ltd IPO allotment status?
You can check Avience Biomedicals Ltd IPO allotment status on IPONOVA after the basis of allotment is finalized, or via the registrar's website using your PAN number, application number, or DP/Client ID.
How to apply for Avience Biomedicals Ltd IPO?
You can apply for Avience Biomedicals Ltd IPO through your broker's app (Zerodha, Groww, Upstox, etc.) or via UPI-enabled net banking using ASBA. Submit the application during the IPO subscription window with the price within the band ₹196.00 to ₹208.00 per share.

Data Sources & Verification

This page aggregates publicly available data for the Avience Biomedicals Ltd IPO from the following authoritative sources:

Subscription, allotment and listing data is refreshed throughout each IPO's issue window directly from the exchanges and registrars listed above. Always read the official offer document (RHP) before applying. For corrections, contact IPONOVA Editorial Desk.

Read our full editorial methodology & sourcing standards →

Disclaimer: IPONOVA is an information platform only. We are not SEBI-registered investment advisors. All data is presented for educational and informational purposes and is sourced from publicly available filings on BSE, NSE and SEBI. Investment in securities market is subject to market risks. Read all related documents carefully before investing. Past performance is not indicative of future returns. Please consult a SEBI-registered investment advisor before making any investment decisions.